Drug Shortage Report for XERESE
Report ID | 183894 |
Drug Identification Number | 02404044 |
Brand name | XERESE |
Common or Proper name | XERESE |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCORTISONE ACYCLOVIR |
Strength(s) | 1% 5% |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 5g |
ATC code | D06BB |
ATC description | CHEMOTHERAPEUTICS FOR TOPICAL USE |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2023-04-21 |
Actual start date | |
Estimated end date | 2023-06-13 |
Actual end date | 2023-04-07 |
Shortage status | Avoided shortage |
Updated date | 2023-04-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-04-11 | French | Compare |
v3 | 2023-04-11 | English | Compare |
v2 | 2023-02-08 | French | Compare |
v1 | 2023-02-08 | English | Compare |
Showing 1 to 4 of 4